Peptides DB
Research-centric peptide and protocol reference hub
Study 7 of 37NAD+ (Nicotinamide Adenine Dinucleotide) literaturebiorxiv-preprint · Observational2026

Functional characterization of a cytosolic malic enzyme crucial for pyridine nucleotide homeostasis, redox balance, and virulence in Leishmania major

LmME2 is crucial for maintaining NAD+ levels and redox balance in Leishmania major, with its deletion leading to increased ROS and reduced virulence in mice.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the nad+ (nicotinamide adenine dinucleotide) corpus
17
Preclinical
15
Observational · this one
0
Open-label
1
Randomised
4
Reviews

Summary and findings

This study characterizes the cytosolic malic enzyme LmME2 in Leishmania major, focusing on its role in pyridine nucleotide homeostasis and virulence. The researchers utilized CRISPR-Cas9 to generate knockout parasites and observed effects on NAD+ and NADP+ levels. The findings indicate that LmME2 is crucial for maintaining redox balance and parasite fitness.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2026

Abstract

The authors’ words, as biorxiv-preprint supplied them

Malic enzymes (MEs) occupy a central node in metabolism, by catalyzing the reversible oxidative decarboxylation of malate to pyruvate, thereby contributing to maintenance of NADPH homeostasis. Leishmania spp. are known to encode two ME isoforms, however only one from Leishmania major has been functionally characterised till date to be a mitochondrial enzyme, playing critical role in gluconeogenesis. Here, we cloned and functionally characterized the second isoform, LmME2. Colocalization and subcellular fractionation analysis established that LmME2 localizes to the cytosol. Kinetic analyses of purified LmME2 revealed comparable rates of malate decarboxylation and pyruvate carboxylation, however, pyruvate carboxylation predominated in parasite cell lysates, indicating that the directionality of the reaction is metabolically regulated in cellular environment. Consistent with this, we identified oxaloacetate, ATP and fumarate as allosteric modulators of LmME2 activity. To dissect its physiological role, we generated CRISPR-Cas9-mediated LmME2 knockout parasites (LmME2 -/- ). Interestingly, LmME2 deletion did not alter NADPH levels but depleted both NADP + and NAD + pools, with reduction in NAD + being more pronounced. This disruption of pyridine nucleotide homeostasis resulted in elevated intracellular ROS levels. Furthermore, inhibition of the pentose phosphate pathway, the alternative cytosolic source of NADPH, severely impaired the growth of LmME2 -/- strain, highlighting the role of LmME2 in maintaining parasite fitness. These metabolic defects translated into markedly diminished intracellular survival of LmME2 -/- parasites and its attenuated virulence in mice. Collectively, our findings identify LmME2 as the first functionally characterized cytosolic malic enzyme in Leishmania and establish it as a redox-associated virulence factor. These results further highlight LmME2 as a promising antileishmanial drug target.

Background

The paper addresses the biological question of how pyridine nucleotide homeostasis and redox balance are maintained in Leishmania major, a pathogen responsible for leishmaniasis. Prior research has established that redox balance is crucial for pathogen survival and virulence, but the specific mechanisms remain unclear. Understanding these mechanisms may provide insights into potential targets for intervention.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Key findings

  • Not reported in abstract.

Limitations

  • Not reported in abstract.

Elsewhere in the NAD+ (Nicotinamide Adenine Dinucleotide) corpus

CThe mitochondrial deacetylase SIRT3 is nonessential for cyclophilin D-dependent procoagulant platelet formation in mice.Platelets · 2026 · Not reported in abstract.AnimalDA comprehensive review of small molecule drugs approved by the FDA in 2025: advance and prospect.Journal of enzyme inhibition and medicinal chemistry · 2026 · 31 of 46 FDA-approved drugs in 2025 were small molecule drugs.reviewCNicotinamide-derived tumor-targeting carbon dots for Cancer Photothermal therapy.Journal of colloid and interface science · 2026 · Binding energy of NAM-CDs to Ki67 was -7.7 kcal/mol.AnimalCMitochondrial-targeted nano-enhancer driving a self-amplifying NAD<sup>+</sup> feedback loop to reprogram MSC spheroids metabolism for accelerated bone regeneration.Biomaterials · 2026In vitroDPyridoxal photoenzymes for asymmetric radical-radical cross-couplings.Nature · 2026CPhage anti-defense genes targeting NAD<sup>+</sup> metabolism and DNA replication are associated with a broad host range against <i>Klebsiella pneumoniae</i>.Virulence · 2026 · Not reported in abstract.Animal